Biological Evaluation of Halogenated Thioureas as Cholinesterases Inhibitors Against Alzheimer’s Disease & Molecular Modeling Studies

Title:Biological Evaluation of Halogenated Thioureas as Cholinesterases Inhibitors Against Alzheimer’s Disease & Molecular Modeling Studies

Volume: 12 Issue: 6

Author(s): Jamshed Iqbal, Sumera Zaib, Aamer Saeed and Muhammad Muddassar

Affiliation:

Keywords: Acetylcholinesterase, alzheimer’s disease, butyrylcholinesterase, docking simulations, halogenated thioureas, homology models.

Abstract: Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibition is thought to be an encouraging approach towards the therapy of Alzheimer’s disease (AD). The current paper targets to give a concise information of mono and dihalo- substituted thioureas similarity with anti-AD potential. The present results represent evaluation of cholinesterase inhibitory potential for halogenated thioureas derivatives. Compound 1t was constituted to be highly potent inhibitor with K_i value 0.12 ± 0.05 µM against AChE, while 1b was most the active inhibitor for BChE with K_i value of 0.03 ± 0.001 µM. Molecular docking simulations were performed using the homology models of both cholinesterases in order to explore the plausible binding modes of synthesized compounds.

Cite this article as:

Iqbal Jamshed, Zaib Sumera, Saeed Aamer and Muddassar Muhammad, Biological Evaluation of Halogenated Thioureas as Cholinesterases Inhibitors Against Alzheimer’s Disease & Molecular Modeling Studies, Letters in Drug Design & Discovery 2015; 12 (6) . https://dx.doi.org/10.2174/1570180812666141201222247